1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Epiomic Epidemiology Series: Huntington’s Disease Forecast in 8 Major Markets 2015-2025

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Huntington’s disease in 8 Major Markets
Presented in an easy to understand table format, this report provides the current prevalent population for Huntington’s disease across 8 Major Markets (USA, France, Germany, Italy, Spain, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report provides a 10-year forecast projection based on population trends in each of the major markets. The report also contains a disease overview including risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Huntington’s patients have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Huntington’s disease include:

-Total functional capacity by stage
-Nervous system dysfunction
-Psychiatric disorders
-Cognitive disorders
-Major depressive disorder
-Personality changes
-Anxiety disorders
-Nocturia
-Moderate / Severe Sleep disturbance

The report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Table Of Contents

Epiomic Epidemiology Series: Huntington’s Disease Forecast in 8 Major Markets 2015-2025
Huntington's disease
Table of Contents
-List of Tables and Figures
-Introduction
-Cause of the Disease
-Risk Factors and Prevention
-Diagnosis of the Disease
-Variation by Geography/Ethnicity
-Disease Prognosis andClinical Course
-Unified Huntington's Disease Rating Scale (UHDRS)
-Total Functional Capacity
-Methodology
-Top-Line Huntington's Disease Prevalence
-Prevalence of UHDRS Components within the Huntington's Disease Cohort
o Total Functional Capacity Stage Breakdown
o Prevalence of Motor Dysfunction in Huntington's Patients
o Prevalence of Behavioural Dysfunction in Huntington's Patients
o Prevalence of Cognitive dysfunction in Huntington's Patients
-References
-Appendix


List of Tables and Figures
-Total functional capacity scores and stages
-Prevalence of Huntington's Disease, total (000s)
-Prevalence of Huntington's Disease, males (000s)
-Prevalence of Huntington's Disease, females (000s)
-Huntington's Disease by TFC stage (000s)
-Huntington's Disease patients with autonomic nervous system dysfunction (000s)
-Huntington's Disease patients with psychiatric disorders (000s)
-Huntington's Disease patients with major depressive disorder (000s)
-Huntington's Disease patients with personality changes (000s)
-Huntington's Disease patients with any anxiety disorder (000s)
-Huntington's Disease patients with cognitive disorders (000s)
-Huntington's Disease patients with nocturia (000s)
-Huntington's Disease patients with moderate o severe sleep disturbance (000s)
-USA Prevalence of Huntington's by 5-yr age cohort, males (000s)
-USA Prevalence of Huntington's by 5-yr age cohort, females (000s)
-France Prevalence of Huntington's by 5-yr age cohort, males (000s)
-France Prevalence of Huntington's by 5-yr age cohort, females (000s)
-Germany Prevalence of Huntington's by 5-yr age cohort, males (000s)
-Germany Prevalence of Huntington's by 5-yr age cohort, females (000s)
-Italy Prevalence of Huntington's by 5-yr age cohort, males (000s)
-Italy Prevalence of Huntington's by 5-yr age cohort, females (000s)
-Spain Prevalence of Huntington's by 5-yr age cohort, males (000s)
-Spain Prevalence of Huntington's by 5-yr age cohort, females (000s)
-United Kingdom Prevalence of Huntington's by 5-yr age cohort, males (000s)
-United Kingdom Prevalence of Huntington's by 5-yr age cohort, females (000s)
-Brazil Prevalence of Huntington's by 5-yr age cohort, males (000s)
-Brazil Prevalence of Huntington's by 5-yr age cohort, females (000s)
-Japan Prevalence of Huntington's by 5-yr age cohort, males (000s)
-Japan Prevalence of Huntington's by 5-yr age cohort, females (000s)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Epilepsy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...

Narcolepsy-Market Insights, Epidemiology and Market Forecast-2023

Narcolepsy-Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Narcolepsy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.